Height—and the genes that influence it—are important predictors for the development of varicose veins, according to a study out of Stanford University.
The Orsiro drug-eluting stent. Photo courtesy of Biotronik.
Resolute Onyx, a polymer-coated zotarolimus-eluting stent, has been proven safe and effective in an all-comer population of more than 2,000 heart patients, according to late-breaking results of the BIONYX trial.
SAN DIEGO — General and local anesthesia are comparably safe and effective during transcatheter aortic valve replacement (TAVR) procedures, according to the first randomized trial to compare the two approaches.
The Abbott MitraClip is the primary structural heart device used in transcatheter edge-to-edge repairs (TEER) of the mitral valve leaflets. Image courtesy of Abbott.
Compared to heart failure patients with severe secondary mitral regurgitation who were treated with guideline-directed medical therapy alone, those randomized to a MitraClip procedure plus optimal medical therapy demonstrated relative reductions of 47 percent for heart failure hospitalizations and 38 percent for mortality at two years of follow-up.
The Orsiro drug-eluting stent. Photo courtesy of Biotronik.
SAN DIEGO — The ultra-thin Orsiro drug-eluting stent (DES) maintained superior outcomes at two years of follow-up in a head-to-head trial against Abbott’s Xience stent, according to results presented this weekend at Transcatheter Cardiovascular Therapeutics 2018 and published online in the Journal of the American College of Cardiology.
A strict protocol mandating coronary angiography and therapeutic hypothermia contributed to “startling” improvements in survival rates for out-of-hospital cardiac arrest (OHCA), researchers reported in JACC: Cardiovascular Interventions.
Atrial fibrillation patients are acutely aware of their five-fold increased risk of stroke, new research from StopAfib.org suggests—and 38 percent report feeling “trapped” between their fear of having a stroke and the major bleeding risks associated with anticoagulants.
Patients who suffer from deep vein thrombosis (DVT) see a “clear benefit” from initiating preventive compression therapy shortly after their diagnosis, as opposed to later stages of treatment, according to a study published this week in the journal Blood.
The proportion of percutaneous coronary interventions (PCIs) performed in nonagenarians has more than doubled in the last decade in the United States, offering a significant survival benefit for those deemed healthy enough for the procedure, according to a study published online Sept. 17 in JACC: Cardiovascular Interventions.
The majority of the world’s countries aren’t on track to meet the United Nations' target of reducing premature deaths from noncommunicable diseases (NCDs) by a third by 2030, researchers report in the current edition of the Lancet.
![Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.](/sites/default/files/styles/top_stories/public/2018-08/olderpatient-doctor.jpg.webp?itok=Cv18wcDr)
